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Chloroform is a common drinking water
disinfection by-product. Recently, present
U.S. Environmental Protection Agency
(U.S. EPA) drinking water standards for
chloroform have been scrutinized (1,2): “Are
today’s standards based on rodent megadose
studies relevant to real world exposures?”
Carcinogenic results in these rodent studies
were found at concentrations several orders
of magnitude higher than the chloroform
maximum contaminant level goal (MCLG)
of 0 mg/L and the total trihalomethane max-
imum contaminant level (MCL) of 0.08
mg/L (3).
Nontraditional models such as fish can
be used to study chloroform-induced toxic-
ity at exposures closer to concentration levels
found in drinking water. Fish have been
shown to be sensitive to trace levels of conta-
minants in aquatic media (4–8). As water-
dwelling organisms, fish receive dermal
exposure through whole-body immersion in
the exposure solution. Intake of test material
also occurs through feeding and respiration.
Japanese medaka have been studied
extensively both in the United States and in
Japan (9–13). Their hardiness, small size,
ease of culturing, and relatively short time-
to-tumor response make the medaka an
attractive test model. Sections of the entire
animal will fit on one microscope slide so
that examination of every tissue is possible in
its anatomical context. The low rate of
spontaneous neoplasms in medaka aids in
the interpretation of bioassay results (14). 
Increased cellular proliferation is necessary
to transform normal tissue to neoplastic tissue
(15). 5-Bromo-2´-deoxyuridine (BrdU), a
thymidine analog that labels cells in S-phase,
has been used extensively to study cellular
proliferation in rodents (16– 18) and fish
(19,20). BrdU cell labeling has been accom-
plished previously via intraperitoneal injec-
tion, implantation of an osmotic pump, and
aqueous exposure (19–24). Previous BrdU
range-ﬁnding studies with medaka in this lab-
oratory have demonstrated an effective cell-
labeling concentration of BrdU in the ambient
water to be 75 mg/L for 72 hr (25,26).
Our purpose was to determine the effect
of chloroform on Japanese medaka after 9
months of continuous exposure. Speciﬁc end
points evaluated were severity and prevalence
of neoplasms, hepatocellular proliferation,
hematology, intrahepatic chloroform con-
centration, ﬁsh growth, and ﬁsh survival.
Materials and Methods
Test materials. Chloroform (CAS No. 67-
66-3) of 99.8% purity was obtained from
Aldrich Chemical Company (Milwaukee,
WI). Weekly chemical analyses of aquaria
water demonstrated that chloroform did not
break down to form other compounds.
Under the continuous flow-through dosing
regimen, sufficient chloroform remained in
solution during testing to maintain dosage
levels. Approximately 10 L of 100 mg/L
chloroform stock were prepared each day.
Processed well water was the diluent used.
The chloroform stocks were stirred for 24 ±
2 hr in a sealed glass container, and then
pumped into a diluter dosing bottle. 
BrdU (CAS No. 59-14-3) of 99% purity
was obtained from Sigma Chemical Co. (St.
Louis, MO). BrdU is water soluble, not
volatile, and stable under test conditions. A
stock solution of 10 g/L BrdU was prepared in
ASTM Type I water on the day of exposure.
Animal care. Research was conducted in
compliance with the Animal Welfare Act
and other federal statutes and regulations
relating to animals and experiments involv-
ing animals, and adheres to principles stated
in the Guide for the Care and Use of
Laboratory Animals (27). The facilities are
fully accredited by the Association for the
Assessment and Accreditation of Laboratory
Animal Care, International. 
Japanese medaka fish (Oryzias latipes)
were supplied from the U.S. Army Center
for Environmental Health Research
(USACEHR) in-house cultures and were
reared according to USACEHR standing
operating procedures. Fish were fed flake
food (Aquatox Certified Diet, Ziegler
Brothers, Gardners, PA) and live 24-hr brine
shrimp daily. Fish were fasted 24 hr before
the 6- and 9-month histopathology sacriﬁces
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Japanese medaka (Oryzias latipes) were continually exposed in a ﬂow-through diluter system for 9
months to measured chloroform concentrations of 0.017, 0.151, or 1.463 mg/L. Parameters eval-
uated were hepatocarcinogenicity, hepatocellular proliferation, hematology, and intrahepatic
chloroform concentration. Histopathology was evaluated at 6 and 9 months. Chloroform was not
hepatocarcinogenic to the medaka at the concentrations tested. Chronic toxicity was evidenced at
these time points by statistically signiﬁcant (α = 0.05) levels of gallbladder lesions and bile duct
abnormalities in medaka treated with 1.463 mg/L chloroform. We assessed hepatocellular prolif-
eration by exposing test ﬁsh to 5-bromo-2´-deoxyuridine in the aquarium water for 72 hr after 4
and 20 days of chloroform exposure; we then quantiﬁed area-labeling indices of the livers using
computer-assisted image analysis. We observed no treatment-related increases in cellular prolifer-
ation. We analyzed cells in circulating blood in medaka after 6 months of chloroform exposure.
Hematocrit, leukocrit, cell viability, and cell counts of treated ﬁsh were not signiﬁcantly different
from those of control ﬁsh. Using gas chromatography (GC), we evaluated intrahepatic concentra-
tions of chloroform in fish after 9 months of exposure. Livers from the 0.151 and 1.463 mg/L
chloroform-treated ﬁsh had detectable amounts of chloroform, but these levels were always lower
than the aquaria concentrations of chloroform. Thus, it appeared that chloroform did not bioac-
cumulate in the liver. Unidentiﬁed presumptive metabolite peaks were found in the GC tracings
of these ﬁsh livers. Key words: aquatic toxicology, 5-bromo-2´-deoxyuridine, carcinogenicity, cell
proliferation, chloroform, fish, hematology, histopathology, medaka, Oryzias latipes. Environ
Health Perspect 109:35–40 (2001). [Online 12 December 2000]
http://ehpnet1.niehs.nih.gov/docs/2001/109p35-40toussaint/abstract.htmland the BrdU exposures. Durotest Optima
Choice fluorescent bulbs with a color ren-
dering index (CRI) of 91 (Durotest
Lighting, Fairfield, NJ) provided the light
for the 16-hr light/8-hr dark cycle of light. 
Test design. We chose the amount of
chloroform routinely found in dechlorinated
tap water as the lowest concentration tested.
In 96-hr range-ﬁnding studies with juvenile
medaka, a length NOEL (no-observed-effect
level) of 21–25 mg/L and a weight NOEL of
22–26 mg/L were established for chloroform
(28). We chose a log scale for the three con-
centrations of chloroform, which  ensured
that all concentrations tested were below the
NOELs established in acute testing. Four
test aquaria were randomly assigned to each
nominal concentration of 0, 0.015, 0.15,
and 1.5 mg/L chloroform.
The test began when 14-day-old fry (± 1
day) were randomized to each 5-gallon test
aquarium, with 80 fry and approximately 15
L test solution per sealed aquarium. The pro-
portional diluter was set to deliver 300 ± 15
mL to each aquarium every 3 min ± 15 sec,
yielding 9–10 tank volumes per day. 
During the first month of chloroform
exposure, ﬁve ﬁsh per aquarium for each of
four time points were used for the hepatocel-
lular proliferation assays. After 6 months of
chloroform exposure, we evaluated 20 fish
per aquarium by histopathology, and an
additional five fish per aquarium by hema-
tology. At 9 months of exposure, ﬁve ﬁsh per
aquarium were used for the chloroform
intrahepatic concentration analysis. We
euthanized all remaining fish to assess the
following tissues by histopathology: bone
(vertebra), brain, chromafﬁn tissue, corpus-
cle of Stannius, esophagus, eye, gallbladder,
gill, heart, hematopoietic tissue, interrenal
tissue, intestine, kidney, liver, nares, ovary,
pancreas, peripheral nerve, pineal organ,
pituitary gland, pseudobranch, skeletal mus-
cle, skin, spinal cord, spleen, stato-acoustic
organ, swim bladder, testis, thymus, thyroid
tissue, urinary bladder, and gross lesions. 
Statistical analyses. We analyzed lengths,
weights, and histopathology data statistically
for the chronic carcinogenicity test. For
these and all other test end points, we
applied normalizing transformations where
required, and selected the best-ﬁtting model
for each test end point. We used analysis of
variance (ANOVA) to test for effects, and
regression analysis for point estimation. We
used SAS PROC GLM computer software
(SAS Institute, Inc., Cary, NC) for these
analyses (29). 
Chloroform chemical analyses. All expo-
sure tanks were sampled weekly and analyzed
on the day of collection. Daily stock solu-
tions were collected and stored at 5°C until
the weekly analysis of the exposure tanks. All
samples were collected in 40 mL borosilicate
glass U.S. EPA water-sampling vials with
Teﬂon-lined silicone rubber septa in the cap.
To analyze samples we used a Hewlett
Packard 6890 gas chromatograph equipped
with an electron capture detector and inter-
faced to Hewlett Packard model 7694 head-
space sampler (Agilent Technologies, Palo
Alto, CA). We used a Hewlett Packard
ChemStation for instrument control and data
acquisition. The capillary column used
throughout the study was a Hewlett Packard
25-m HP-1 (cross-linked methyl polysilox-
ane), 0.2 mm i.d. and 0.33 µm ﬁlm thickness.
The oven temperature of the gas chromato-
graph held isothermally at 40°C, the inlet was
set at 250°C, and the electron capture detec-
tor was maintained at 300°C.
We chose headspace analysis for this
study for its sensitivity, simplicity, and rapid
throughput. Headspace analysis has been
used elsewhere to analyze rat liver, urine, and
blood (30,31) and was applied here to fish
tissue and water samples. For the weekly
analysis of exposure tanks, three 5 mL
aliquots of each sample were placed in 10
mL headspace vials and sealed with Teﬂon-
lined crimp caps. The vials were then placed
in the headspace sampler with the sampler
oven set at 60°C, the 1 mL sample loop at
65°C, and the transfer line to the gas chro-
matograph at 70°C. The sample vial equili-
bration time was 30 min with agitation set
on high. External calibration standards were
used for this method and prepared fresh on
the day of analysis. The technique required
no further sample preparation and there
were no interfering contaminants from the
sample matrix. The detection limit was
0.003 mg/L and the recovery was 95.2%.
BrdU chemical analyses. We collected
samples for chemical analysis at the initiation
and termination of each exposure. Spiked
samples showed an average recovery of 102%.
We used a Hewlett Packard 1050 series high
performance liquid chromatograph equipped
with a variable wavelength detector, autosam-
pler, and Hewlett Packard Chemstation
(Agilent Technologies) to analyze BrdU sam-
ples. Samples were ﬁltered through a 0.45 µm
membrane before analysis. The solvent deliv-
ery system was programmed to deliver 15%
methanol/85% water at a flow rate of 1.5
mL/min. The UV detector was set at 277 nm
to monitor the eluate. A Supelco TM LC-18
column (25 cm × 0.46 i.d., 5 µm particle size;
Supelco, Bellefonte, PA) was used for the sep-
aration. The injection volume was 5 µL.
Hepatocellular proliferation assays. Five
ﬁsh per aquarium were removed from each of
the 16 test aquaria on test days 2, 4, 7, and
20, exposed to 75 mg/L BrdU for 72 ± 4 hr,
and euthanized with an overdose of tricaine
methane sulfonate (MS-222) on test days 5,
7, 10, and 23, respectively. BrdU exposure,
fixation, sectioning, staining, and counting
methods have been described previously (26).
We used a Bioquant/True Color Image
Analysis System (Bioquant-R&M Biometrics,
Inc., Nashville, TN) to evaluate BrdU-labeled
slides, with ﬁve BrdU-stained sections from
each ﬁsh. A count labeling index (CLI) was
done to validate the area labeling index (ALI)
method and to ensure that hepatic cell size
did not change due to chloroform treatment.
R2 values comparing the CLI and ALI for the
4-day and 20-day sacriﬁce points were 0.934
and 0.921, respectively.
Chronic carcinogenicity. At 6 and 9
months of chloroform exposure, fish were
euthanized with an overdose of MS-222.
Fish necropsy procedures, fixation, section-
ing, and staining were done as described pre-
viously (32). Fish tissues, listed in “Test
Design,” were evaluated by histopathology.
Fish hematology. During the ﬁsh chronic
test, ﬁve ﬁsh per aquarium were removed after
6 months of continuous exposure to chloro-
form. Fish were euthanized by an overdose of
MS-222, and then weighed and measured. A
capillary tube (10–20 µL) of blood was
removed from each ﬁsh, and each ﬁsh’s ante-
rior kidneys, a major site of hematopoeisis,
were excised. Hematocrit and leukocrit were
measured for each blood sample. Cell counts
were performed using a hemacytometer. Cell
viability was assessed (trypan blue exclusion)
from kidney cell suspensions. 
Fish intrahepatic chloroform concentra-
tion. At 9 months of chloroform exposure,
five fish per aquarium were removed from
the test for analysis of chloroform intrahep-
atic concentration. Fish were euthanized
with an overdose of MS-222, weighed, and
measured. The livers were excised, weighed,
ﬂash frozen in individual cryovials in liquid
nitrogen, and then stored at –70°C. On the
day of analysis, livers were thawed and trans-
ferred to 10 mL glass head space vials con-
taining 5 mL of 2% (w/v) sodium dodecyl
sulfate (SDS). Two percent SDS was added
to denature liver enzymes immediately, thus
terminating metabolism. The vials were
capped and heated at 60°C for 2 hr before
headspace analysis by capillary gas chro-
matography (as described in “Chloroform
Chemical Analyses”). The detection limit for
chloroform in the SDS solution was 0.5
µg/L, which was converted to milligrams of
chloroform per gram of liver tissue. Recovery
was 95.2%.
Results
Water quality. Water quality parameters
monitored were temperature, pH, dissolved
oxygen, conductivity, alkalinity, hardness,
and un-ionized ammonia. All water quality
parameters were within acceptable limits
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our laboratory diluent water.
Chloroform chemical analyses. Over 9
months, we performed 38 weekly chemical
analyses on each aquarium. Mean measured
concentrations (replicates combined) yielded
measured test concentrations of 0, 0.017 ±
0.004, 0.151 ± 0.034, and 1.463 ± 0.242
mg/L. 
Hepatocellular proliferation assays. Two
of the four hepatocellular proliferation tests
had unacceptable mortality (> 10%) in con-
trol and treated groups. In the remaining two
cell proliferation time points, survival was
100%. Mean measured BrdU concentration
for all treatments was 74.3 ± 2.8 mg/L.
Results from the two acceptable tests, time
point 2 (4 days of chloroform exposure) and
time point 4 (20 days of chloroform expo-
sure), suggested chloroform treatment-related
effects on hepatocellular proliferation at the
concentrations tested (mean values for 20
days of chloroform exposure: 0.014, 0.120,
and 1.141 mg/L) at time point 2 but not at
time point 4. These results were not statisti-
cally signiﬁcant, however.
Fish growth and survival. Mortality
through the 9-month exposure period was <
4% in all control and treated groups.
Growth measurements are summarized in
Table 1. At 6 months, there was a suggestion
of growth reduction, but these results were
not statistically significant. Comparison of
estimated means and their 95% confidence
limits revealed a reduction in ﬁsh length (f =
7.66, p = 0.0059) with the highest test-con-
centration fish smaller than control fish,
23.8 mm (23.43, 24.18) and 24.8 mm
(24.23, 25.47), respectively. There was also a
reduction in ﬁsh weight (f = 5.41, p = 0.025)
overall. At 9 months, no reduction in
growth was found for length (f = 3.22, p =
0.0732) or weight (f = 1.58, p = 0.2090). 
Fish histopathology. At 6 months of chlo-
roform exposure, the only significant (f =
10.74, p = 0.0055) ﬁnding for males at the
1.464 mg/L concentration was proliferation,
or hyperplasia, of bile ducts of the liver. In
contrast, female medaka at the 1.464 mg/L
concentration exhibited nine signiﬁcant ﬁnd-
ings in the bile ducts of the liver and the gall-
bladder. As in males, females had an increase
(f = 23.46, p = 0.0003) in bile duct hyperpla-
sia. Additionally, females had bile duct
epithelium hyperplasia (f = 7.84, p = 0.0142),
dilatation of the bile ducts (f = 18.93, p =
0.0007), and concretions in the lumen (f =
42.98, p = 0.0001). Granulomatous peri-
cholangitis—an inflammation around bile
ducts characterized mainly by macrophages
with variable numbers of lymphocytes—sig-
niﬁcantly (f = 31.62, p = 0.0001) occurred in
females, presumably as a result of bile leakage
into the liver parenchyma. Concretions also
signiﬁcantly (f = 35.39, p = 0.0001) occurred
in the lumen of the gallbladder. The epithe-
lium of the cystic duct as well as the gallblad-
der itself exhibited signiﬁcant hyperplasia (f =
36.17, p = 0.0001 and f = 19.94, p = 0.0005,
respectively). Dilatation of the cystic duct
was significant (f = 10.60, p = 0.0057) in
female medaka.
After 9 months of exposure to various
concentrations of chloroform, there were sig-
nificant differences overall between males
and females in their responses to chloroform
for gallbladder concretions (f = 5.76; p =
0.0231), cystic duct hyperplasia (f = 4.94; p
= 0.0341), and bile duct epithelium hyper-
plasia (f = 6.43, p = 0.0169). These changes
occurred with greater frequency among
females than among males.
At 9 months and with increased mea-
sured chloroform concentrations, males
demonstrated a significantly (f = 9.57; p =
0.0079) higher incidence of  dilatation  of
the cystic duct of the gallbladder and a ten-
dency toward a significantly (f = 4.12; p =
0.0617) higher incidence of hyperplasia of
the epithelium of the gallbladder. Females
responded to increased measured chloroform
concentrations with a higher incidence of
hyperplasia of the cystic duct of the gallblad-
der (f = 25.73, p = 0.0002), hyperplasia of
the gallbladder epithelium (f = 5.94, p =
0.0287), concretions in the lumen of the
gallbladder (f = 32.51, p = 0.0001), and
granulomatous inflammation in the wall of
the gallbladder (granulomatous cholecystitis)
(f = 8.30, p = 0.0121) characterized by the
presence of macrophages and lymphocytes. 
Few liver neoplasms were observed for
control and treated ﬁsh at 6 and 9 months.
One hepatocellular adenoma, a benign neo-
plasm of hepatocytes, was observed in a
male exposed to 0.151 mg/L chloroform
for 6 months, while no malignant hepato-
cellular neoplasms occurred in any 6-
month-exposed fish. At 9 months, one
hepatocellular carcinoma (a malignant neo-
plasm of hepatocytes) was observed in a
control female. Two hepatocellular adeno-
mas occurred in medaka examined at 9
months: one in a male treated with 0.017
mg/L chloroform and one in a female
treated with 0.151 mg/L chloroform. 
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Table 1. Fish chronic chloroform exposure: 9-month survival and growth.
Chloroform Mean Mean  Treatment Treatment
treatment  Percent wet weight  standard mean weight  mean length 
(mg/L) Replicates survival (mg) length (mm) (mg) (mm)
Well-water 1 100 296 25.3 297 24.9
controls 2 99 301 24.9
3 96 297 24.8
4 99 294 24.7
0.017 1 96 277 25.2 289 24.8
2 96 282 24.5
3 94 311 25.2
4 94 288 24.4
0.151 1 99 293 25.0 291 25.0
2 99 300 25.3
3 99 290 25.0
4 96 282 24.7
1.463 1 90 280 24.8 283 24.4
2 98 279 24.2
3 98 291 24.9
4 98 282 23.8
Table 2. Histopathology of male medaka after chloroform exposure through 6 and 9 months: prevalence of
ﬁndings.
Control 0.017 mg/L 0.151 mg/L 1.463 mg/L
Tissues  (6 m, 9 m) (6 m, 9 m) (6 m, 9 m) (6 m, 9 m)
Gallbladders examined 46, 53 32, 46 44, 47 31, 47
Cholecystitis, granulomatous 0, 0 0, 0 0, 0 0, 0
Concretions 0, 0 0, 0 0, 1 0, 3
Cystic duct concretions 0, 0 0, 0 1, 0 0, 0
Cystic duct dilatation 0, 0 0, 0 1, 0 1, 2
Cystic duct hyperplasia 0, 0 0, 0 0, 0 0, 0
Epithelium hyperplasia 0, 0 0, 0 1, 1 0,2
Livers examined 47, 53 34, 46 46, 47 34, 49
Bile duct concretions 0, 0 0, 1 0, 0 0, 2
Bile duct dilatation 1, 4 1, 5 1, 11 1, 9
Bile duct epithelium hyperplasia 0, 0 0, 0 0, 0 1, 0
Bile duct hyperplasia 0, 0 0, 0 0, 2 2, 1
Pericholangitis, granulomatous 0, 0 0, 0 0, 0 0, 1
m, months.A tabular summary of non-neoplastic tis-
sue alterations in and around the liver in
males is shown in Table 2, females in Table
3. Trends seen in the occurrence of gallblad-
der lesions and bile duct abnormalities at 6
months were confirmed at 9 months.
Representative photomicrographs of tissue
alterations occurring at the 1.463 mg/L level
of chloroform are shown in Figures 1 and 2. 
Table 4 shows relevant ﬁndings at 6 and
9 months where responses were observed at
both time points. The overall trend of the
data was to have ﬁndings of no signiﬁcance
or marginal signiﬁcance at 6 months and to
have a signiﬁcant ﬁnding at 9 months, except
for cystic duct concretions in 6-month
females and bile duct hyperplasia in 9-month
males, which showed the opposite trend.
Fish hematology test. The hematology
analysis was conducted after 6 months of
chloroform exposure. ANOVA performed
on data from chloroform-treated fish for
hematocrit, leukocrit, cell viability, and cell
count demonstrated that none of these para-
meters were significantly different from
those of controls (p = 0.05).
Fish intrahepatic concentration. We
detected no chloroform in any of the 20 ﬁsh
livers from the 0 or the 0.017 mg/L aquaria
concentration groups. Of the 20 fish ana-
lyzed in the 0.151 mg/L aquaria concentra-
tion group, 2 fish livers had measured
concentrations of chloroform (33 and 133
mg chloroform/g of ﬁsh liver). At the 1.463
mg/L aquaria chloroform concentration, 9
fish livers out of the 20 sampled had
detectable amounts of chloroform (23, 26,
35, 41, 128, 144, 159, 194, and 219 mg/g). 
One or two other unidentifiable peaks
were seen frequently on the chloroform chro-
matographs, as illustrated by a representative
chromatograph in Figure 3. One of these
peaks was in size equal to or greater than the
chloroform peak. Repeated attempts to iden-
tify these other peaks through related experi-
ments have not yet been successful. 
Discussion
In medaka exposed to chloroform concentra-
tions ranging from 0.017 to 1.463 mg/L,
induction of liver neoplasms due to chloro-
form exposure was not signiﬁcantly different
(α = 0.05) in treated ﬁsh when compared to
control ﬁsh, after 6 or 9 months of exposure.
Gallbladder abnormalities and bile duct
abnormalities were observed in treated ﬁsh at
significantly increased frequencies at the
1.463 mg/L chloroform level. Chloroform
was not hepatocarcinogenic to the medaka
after 6 or 9 months of exposure. 
Numerous pathology findings were dis-
similar between chloroform-exposed rodents
and the current ﬁsh study. In rats (477 mg/kg
chloroform/day, 48-hr duration, single gavage
dose) and mice (30 ppm chloroform, 90-day
duration, inhalation; and 30 ppm, 14 days of
dosing with 2-year duration, inhalation),
males had a greater sensitivity to chloroform
presumably through testosterone receptor
mechanisms in the proximal convoluted
tubular cells (33–36). In medaka, females
demonstrated a greater sensitivity to chloro-
form at both 6 and 9 months. Chloroform
target organs in rodents were kidney, liver,
and nasal passages (33–35), while in medaka
only the gallbladder and bile ducts showed
tissue abnormalities. In an inhalation study,
rats that were exposed to 300 mg/L chloro-
form developed intestinal crypt-like ducts
with periductular fibrosis from nonbiliary
cells in their livers (37). No such correspond-
ing abnormality was observed during fish
pathology in the current study. Interestingly,
the rodent studies revealed an association
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Table 3. Histopathology of female medaka after chloroform exposure through 6 and 9 months: prevalence
of ﬁndings.
Control 0.017 mg/L 0.151 mg/L 1.463 mg/L
Tissues (6 m, 9 m) (6 m, 9 m) (6 m, 9 m) (6 m, 9 m)
Gallbladders examined 31, 62 43, 54 34, 66 48, 55
Cholecystitis, granulomatous 0, 0 0, 0 0, 0 1, 3
Concretions 0, 1 0, 1 0, 5 9, 16
Cystic duct concretions 0, 1 1, 1 0, 1 2, 0
Cystic duct dilatation 0, 0 0, 0 0, 0 3, 1
Cystic duct hyperplasia 0, 0 1, 0 0, 0 1, 6
Epithelium hyperplasia 0, 0 0, 0 0, 2 5, 4
Livers examined 33, 62 47, 58 34, 67 48, 57
Bile duct concretions 0, 0 0, 1 0, 0 5, 6
Bile duct dilatation 1, 4 0, 4 0, 8 10, 12
Bile duct epithelium hyperplasia 0, 0 0, 0 0, 0 3, 4
Bile duct hyperplasia 0, 0 0, 1 0, 0 2, 7
Pericholangitis, granulomatous 0, 0 0, 0 0, 0 3, 4
m, months.
Figure 1. Hematoxylin and eosin-stained slides of medaka tissue after 9 months of continuous dosing. (A)
Liver and gallbladder (arrows) with concretions in chloroform-treated fish (1.463 mg/L tank concentra-
tion); the gallbladder wall was thickened by a granulomatous inﬂammation. (B) Control liver from a ﬁsh of
the same age. Bar = 300 µm. 
Figure 2. Hematoxylin and eosin-stained slides of medaka liver samples. (A) Biliary hyperplasia in liver of a
ﬁsh treated for 9 months (1.463 mg/L chloroform). (B) Liver of a control ﬁsh of the same age. Bar = 300 µm.between hepatocyte labeling indices and
prevalence of aberrant ducts (23,33–35). In
the fish, we saw no concurrent increase in
hepatocyte labeling and tissue abnormalities.
Some of these differences can be attributed to
route of exposure and applied concentration
levels, while others are undoubtedly related to
choice of animal model.
The reason for the occurrence of concre-
tions in the gallbladder and the bile ducts of
the medaka is unknown. Concretions are
rare in animals (38,39). Previously, biliary
concretions have been identified in mon-
keys, cattle, and pigs (39). The principal
constituents of these concretions were cho-
lesterol, precipitated bilirubin, and calcium
carbonate, respectively. When concretions
occur, it is not unusual for them to be com-
posites of these three materials (39). The
cause of these concretions is usually an infec-
tion. In sheep choleliths (concretions),
Pseudomonas aeruginosa has been identified
as the infectious agent (39). The mechanism
for formation is usually solid particles of
dead organisms serving as a nidus for crystal-
lization. Additionally, disturbances in the
resorptive activities in the gallbladder may
promote the development of concretions
(38). Further investigations are necessary to
determine the origin and makeup of these
concretions in chloroform-treated medaka.
Hepatocellular proliferation in chloro-
form-treated ﬁsh livers was not signiﬁcantly
different from proliferation rates observed in
control ﬁsh livers at 4 and 20 days of chloro-
form exposure. The exact cause of ﬁsh death
in the other cell proliferation time points
was not determined, but we suspect that the
high mortality resulted from fungal and bac-
terial contamination in the stagnant
processed well water delivery line used to
make the BrdU exposure solutions. 
Rodent studies have shown a positive
association between increased cell prolifera-
tion and the hepatocarcinogenicity of a com-
pound (2,40,41). In a previous study (26),
this relationship between carcinogenicity and
cell proliferation was also seen in the medaka
after a 48-hr exposure to the liver carcinogen,
diethylnitrosamine. 
Intrahepatic chloroform concentration
was less than external aquaria concentra-
tions, with a higher number of fish livers
containing chloroform at the 1.463 mg/L
concentration. Phosgene is a known mam-
malian metabolite of chloroform (42), but
we did not conﬁrm its presence in ﬁsh livers
exposed to chloroform. Chloroform does not
appear to have bioconcentrated in ﬁsh liver;
the chloroform intrahepatic concentration
was always lower than the external aquarium
concentration.
Chloroform was not acutely toxic to ﬁsh
at concentrations two or three orders of
magnitude above median drinking water lev-
els. Chronic toxicity effects of chloroform
were demonstrated by statistically signiﬁcant
ﬁndings in the gallbladder and bile ducts of
ﬁsh treated with 1.463 mg/L chloroform. 
Given the significant biliary findings
observed at the high concentrations without a
similar early induction of cell proliferation, it
is intriguing to hypothesize that in initiated
populations of cells (43), chronic exposure to
the high concentration of chloroform may
promote biliary carcinogenesis. It is also signif-
icant that although we observed no evidence
of early hepatocellular necrosis and compen-
satory hyperplasia, the highest concentration
of chloroform appeared to cause a chronic
hyperplasia in animals sacrificed after 9
months of exposure. Further studies are war-
ranted with this nonmammalian vertebrate
model to add to the weight of evidence in
public health decisions about balancing
potential disinfection by-product toxicity and
disease risk from microbial contamination.
REFERENCES AND NOTES
1. Stone R. A Molecular approach to cancer. Science
268:356–357 (1995).
2. Golden RF, Holm SE, Robinson DE, Julkunen PH, Reese EA.
Chloroform mode of action: implications for cancer risk
assessment. Regul Toxicol Pharmacol 26:142–155 (1997).
3. U.S. EPA. National Primary Drinking Water Regulations:
Disinfectants and Disinfection Byproducts; Final Rule. 40
CFR Parts 9, 141, and 142. Available: http://www.epa.gov/
OGWDW/mdbp/dbpfr.html [cited 7 January 2000].
4. Metcalfe CD. Tests for predicting carcinogenicity in ﬁsh.
CRC Rev Aquat Sci 1:111–129 (1989).
5. Powers DA. Fish as model systems. Science 246:352–358
(1989).
6. Walker WW, Manning CS, Overstreet RM, Hawkins WE.
Development of aquarium ﬁsh models for environmental
carcinogenesis: an intermittent ﬂow exposure system for
volatile, hydrophobic chemicals. J Appl Toxicol 5:255–260
(1985).
7. Gardner HS, van der Schalie WH, Wolfe MJ, Finch RA.
New methods for on-site biological monitoring of efﬂuent
water quality. In: In Situ Evaluations of Biological Hazards
of Environmental Pollutants (Sandhur SS, Lower WR, de
Serres FJ, Shuk WA, Tice RR, eds). New York:Plenum,
1990;61–69.
8. Twerdok LE, Burton DT, Gardner HS, Shedd TR, Wolfe
MJ. The use of nontraditional assays in an integrated
environmental assessment of contaminated ground
water. Environ Toxicol Chem 9:1816–1820 (1997).
9. Ishikawa T, Shimamine T, Takayama T. Histologic and
electron microscopy observations of diethylnitrosamine-
induced hepatomas in small aquarium fish (Oryzias
latipes). J Natl Cancer Inst 55(4):909–916 (1975).
10. Hatanaka J, Doke N, Harada T, Aikawa, Enomoto M.
Usefulness and rapidity of screening for the toxicity and
carcinogenicity of chemicals in medaka, Oryzias latipes.
Jpn J Exp Med 52(5):243–253 (1982).
11. Hinton DE, Hampton JA, McCusky PA. Japanese medaka
liver tumor model: review of literature and new ﬁndings.
In: Water Chlorination: Chemistry, Environmental Impact,
and Health Effects, Vol 5 (Jolley R, Bull R, Davis W, Katz
S, Roberts M, Jacobs V, eds). Chelsea, MI:Lewis,
1985;439–450. 
12. Hawkins WE, Overstreet RM, Walker WW. Carcinogenicity
tests with small fish species. Aquat Toxicol 11:113–128
(1988).
13. Gardner HS, Brennan LM, Toussaint MW, Rosencrance
AB, Boncavage-Hennessey EM, Wolfe MJ. Environmental
complex mixture toxicity assessment. Environ Health
Perspect 106(suppl 6):1299–1305. (1998). 
14. Hawkins WE, Walker WW, Overstreet RM. Carcinogenicity
tests using aquarium fish. Toxicol Methods 5:225–263
(1995). 
15. Goldsworthy TL, Morgan KT, Popp JA, Butterworth BE.
Guidelines for measuring chemically induced cell prolif-
eration in specific rodent target organs. In: Chemically
Induced Cell Proliferation: Implications for Risk
Assessment (Butterworth BE, Slaga TJ, Farland W,
McClain M, eds). New York:Wiley-Liss, Inc., 1991;253–284. 
16. Weghorst CM, Henneman JR, Ward JM. Dose response
of hepatic and renal DNA synthetic rates to continuous
exposure to bromodeoxyuridine (BrdU) via slow-release
pellets or osmotic minipumps im male B6C3F1 mice. J
Histochem Cytochem 39:177–184 (1991).
17. Connolly KM, Bogdanffy MS. Evaluation of proliferating
cell nuclear antigen (PCNA) as an endogenous marker of
cell proliferation in rat liver: a dual stain comparison with
5-bromo-2’-deoxyuridine. J. Histochem Cytochem 41:1–6
(1993).
18. Constan AA, Yang RSH, Baker DC, Benjamin SA. A unique
Articles • Chloroform chronic toxicity to fish
Environmental Health Perspectives • VOLUME 109 | NUMBER 1 | January 2001 39
Table 4. Chloroform concentration effectsa on ﬁsh histopathology end points at 6 and 9 months, by sex. 
Males Females
End point 6 months 9 months 6 months 9 months
Gallbladder
Cystic duct dilatation No Marginal NF NF
Epithelium hyperplasia No Marginal NF NF
Granulomatous cholecystitis NF NF Marginal Yes
Concretions NF NF Yes Yes
Cystic duct concretions NF NF No Yes
Liver
Bile duct concretions Marginal No Yes Yes
Bile duct dilatation No No Yes Yes
Bile duct epithelium hyperplasia NF NF Yes Yes
Bile duct hyperplasia Yes No Yes Yes
Granulomatous pericholangitis NF NF Yes Yes
Abbreviations: Marginal, p > 0.05 ≤ 0.10; NF, none found; No, p > 0.10; Yes, p < 0.05. 
aANOVA signiﬁcance level = 0.05.
Figure 3. Chromatogram of a ﬁsh liver sample used
to determine intrahepatic chloroform concentra-
tion in medaka ﬁsh exposed to 1.463 mg/L chloro-
form for 9 months. Peaks include the injection
peak, two unknown peaks, and the chloroform
peak, respectively. Instrumental detection limits of
chloroform were 0.001 mg/L.
0123
Time (min)
R
e
s
p
o
n
s
e
Inj. 35 mg CHCI3/g fish liverpattern of hepatocyte proliferation in F344 rats following
long-term exposures to low levels of a chemical mixture
of groundwater contaminants. Carcinogenesis 16:303–310
(1995).
19. Moore MJ, Leavitt DF, Shumate AM, Alatalo P,
Stegeman JJ. A cell proliferation assay for small ﬁsh and
aquatic invertebrates using bath exposure to bromo-
deoxyuridine. Aquat Toxicol 30:183–188 (1994).
20. Koza RA, Moore MJ, Stegeman JJ. Elevated ornithine
decarboxylase activity, polyamines and cell proliferation
in neoplastic and vacuolated liver cells of winter ﬂounder
(Pleuronectes americanus). Carcinogenesis 14:399–405
(1993).
21. Droy BF, Miller MR, Freeland TM, Hinton DE.
Immunohistochemical detection of CCL4-induced, mito-
sis-related DNA synthesis in the livers of trout and rat.
Aquat Toxicol 13:155–166 (1988).
22. Elridge SR, Tilbury LF, Goldsworthy TL, Butterworth BE.
Measurement of chemically induced cell proliferation in
rodent liver and kidney: a comparison of 5-bromo-2´-
deoxyuridine and [3H]thymidine administered by injection
or osmotic pump. Carcinogenesis 11:2245–2251 (1990).
23. Reimschuessel R, Bennett RO, May EB, Lipsky MM.
Renal tubular cell regeneration, cell proliferation and
chronic nephrotoxicity in the goldﬁsh Carassius auratus
following exposure to a single sublethal dose of dex-
achlorobutadiene. Dis Aquat Org 8:211–224 (1990).
24. Van der Hoeven JCM, Bruggeman IM, Alink GM,
Koeman JH. The killiﬁsh Nothobranchius rachowi, a new
animal in genetic toxicology. Mutat Res 97:35–42 (1982).
25. Gardner HS. A New Model for the Examination of Altered
Cell Proliferation in Chemically Induced Hepato-
carcinogenesis [PhD Thesis]. Baltimore, MD:Johns
Hopkins University, School of Public Hygiene and Public
Health, 1996.
26. Brennan LM, Boncavage-Hennessey EM, Wolfe MJ,
Toussaint MW, Gardner HS. An in vivo method for using 
5-bromo-2´-deoxyuridine (BrdU) as a marker of chemi-
cally-induced hepatocellular proliferation in the Japanese
medaka (Oryzias latipes). Toxicol Pathol (in press).
27. Institute of Laboratory Animal Resources. Guide for the
Care and Use of Laboratory Animals. Washington,
DC:National Academy Press, 1996
28. Toussaint MW, Brennan LM, Rosencrance AB, Dennis
WE, Hoffmann FJ, Gardner HS. Acute toxicity of four drink-
ing water disinfection byproducts to juvenile Japanese
medaka ﬁsh. Bull Environ Contam Toxicol (in press).
29. SAS Institute Inc. SAS/STATTM User Guide. Release
6.03 ed. Cary, NC:SAS Institute, 1988. 
30. Koppen B, Delgarrd L. Determination of trichlorethylene
metabolites in rat liver homogenate using headspace
chromatography. J Chromatogr 442:325–332 (1988).
31. Christensen JM, Rasmussen K, Koppen B. Automatic
headspace gas chromatography for the simultaneous
determination of trichloroethylene and metabolites in
blood and urine. J Chromatogr 442:317–323 (1988). 
32. Toussaint MW, Wolfe MJ, Burton DT, Hoffmann FJ, Shedd
TR, Gardner HS. Histopathology of Japanese medaka
(Oryzias latipes) chronically exposed to a complex envi-
ronmental mixture. Toxicol Pathol 27(6):652–663 (1999).
33. Templin MV, Jamison KC, Wolf DC, Morgan KT,
Butterworth BE. Comparison of chloroform-induced toxi-
city in the kidneys, liver, and nasal passages of male
Osborne-Mendel and F-344 rats. Cancer Lett 104:71–78
(1996).
34. Templin MV, Jamison KC, Sprankle CS, Wolf DC, Wong
BA, Butterworth BE. Chloroform-induced cytotoxicity
and regenerative cell proliferation in the kidneys and
liver of BDF1 mice. Cancer Lett 108:225–231 (1996).
35. Larson JL, Templin MV, Wolf DC, Jamison KC, Leninger
JR, Mery S, Morgan KT, Wong BA, Conolly RB,
Butterworth BE. A 90-day chloroform inhalation study in
female and male B6C3F1 mice: implications for cancer
risk assessment. Fundam Appl Toxicol 30:118–137 (1996).
36. Hill RN. Differential toxicity of chloroform in the mouse.
In: Aquatic Pollutants and Biologic Effects with
Emphasis on Neoplasia, Vol 298 (Kraybill HF, Dawe CJ,
Harsbarger JC, Tardiff RG, eds). New York:New York
Academy of Sciences, 1977;170–176.
37. Jamison KC, Larson JL, Butterworth BE, Harden R,
Skinner BL, Wolf DC. A non-bile duct origin for intestinal
crypt-like ducts with periductular ﬁbrosis induced in liv-
ers of F344 rats by chloroform inhalation. Carcinogenesis
17(4):675–682 (1996).
38. Jubb KVF, Kennedy PC, Palmer N. Pathology of Domestic
Animals. New York:Academic Press, Inc., 1985.
39. Jones TC, Hunt RD. Veterinary Pathology. Philadelphia,
PA: Lea and Febiger, 1983.
40. Cunningham ML, Mathews HB. Relationship of hepato-
carcinogenicity and hepatocellular proliferation induced
by mutagenic noncarcinogens vs carcinogens. Toxicol
Appl Pharmacol 110:505–513 (1991).
41. Kato M, Popp JA, Connolly RB, Cattley RC. Relationship
between hepatocyte necrosis, proliferation, and initia-
tion induced by diethylnitrosamine in the male F344 rat.
Fundam Appl Toxicol 20:155–162 (1993). 
42. Gemma S, Faccioli S, Chieco P, Sbraccia M, Testai E, and
Vittozzi L. In vivo CHCL3 bioactivation, toxicokinetics, toxic-
ity, and induced compensatory cell proliferation in B6C3F1
male mice. Toxicol Appl Pharmacol 141:394–402 (1996).
43. Pitot HC, Goldsworthy TL, Moran S, Kennan W, Glaubert
HP, Maronpot RW, Campbell HA. A method to quantitate
the relative initiating and promoting potencies of hepato-
carcinogenic agents in their dose-response relationships
to altered hepatic foci. Carcinogenesis 8(10):1491–1499
(1987).
Articles • Toussaint et al.
40 VOLUME 109 | NUMBER 1 | January 2001 • Environmental Health Perspectives
Check us out!
The Environmental Health Information Service (EHIS) offers online, searchable
access to:
• • Environmental Health Perspectives
• • Environmental Health Perspectives Supplements
• • National Toxicology Program Technical and Toxicity Reports
• • Report on Carcinogens
• • Chemical Health and Safety Database
• • Rodent Historical Control Database
For more information on ordering see http://ehis.niehs.nih.gov/ or call 1-800-315-3010.
http://ehis.niehs.nih.gov/